These results were achieved in controlled clinical trial settings with comprehensive lifestyle support, regular monitoring, and high adherence rates
Your chosen specialist will work on coordinating the schedule with you through your Teladoc Health account
All 3 specimens showed identical features including basilar pigmentation, occasional melanophages in the papillary dermis, and no evidence of nests or pagetoid spread of atypical melanocytes (Figures 2 and 3)
Areas of interest include, but are not limited to: Classic antidiabetic, anti-obesity and cardioprotective effects Cardiovascular outcomes and mechanistic correlates Endothelial and vascular biology Myocardial metabolism and heart failure subtypes Novel renal and hepatoprotective actions Optimization and individualized use of existing GLP-1 receptor agonists Development of novel GLP-1 receptor agonists and multi-agonist (dual and triple) strategies Emerging extra-metabolic actions, including anti-inflammatory and neuroprotective effects Combination therapies, including co-formulations with insulin or SGLT2 inhibitors Innovative delivery systems, including non-injectable and implantable approaches Real-world comparative effectiveness, long-term safety, adherence and treatment durability This Collection welcomes original research, translational studies, and comprehensive reviews and meta-analyses that provide novel mechanistic insight or clinically relevant evidence to advance understanding of the expanding role of incretin-based therapies in cardiometabolic medicine
[RELATED: Eli Lillys Mounjaro Doesnt Need Separate Approval for Sleep Apnea, Says EMA] In adults on PAP therapy, Zepbound led to 29 fewer breathing disruptions per hour compared to six with placebo
Cell 187 , 53935412.e30 (2024)
